Cargando…

Clinical development of placental malaria vaccines and immunoassays harmonization: a workshop report

Placental malaria caused by Plasmodium falciparum infection constitutes a major health problem manifesting as severe disease and anaemia in the mother, impaired fetal development, low birth weight or spontaneous abortion. Prevention of placental malaria currently relies on two key strategies that ar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chêne, Arnaud, Houard, Sophie, Nielsen, Morten A., Hundt, Sophia, D’Alessio, Flavia, Sirima, Sodiomon B., Luty, Adrian J. F., Duffy, Patrick, Leroy, Odile, Gamain, Benoit, Viebig, Nicola K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Meeting Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027113/ https://www.ncbi.nlm.nih.gov/pubmed/27639691 http://dx.doi.org/10.1186/s12936-016-1527-8

Ejemplares similares

Down-selection of the VAR2CSA DBL1-2 expressed in E. coli as a lead antigen for placental malaria vaccine development
por: Chêne, Arnaud, et al.
Publicado: (2018)

Preclinical immunogenicity and safety of the cGMP-grade placental malaria vaccine PRIMVAC
por: Chêne, Arnaud, et al.
Publicado: (2019)

Progress and Insights Toward an Effective Placental Malaria Vaccine
por: Gamain, Benoît, et al.
Publicado: (2021)

Workshop report: Immunoassay standardisation for “universal” influenza vaccines
por: Pavlova, Sophia, et al.
Publicado: (2017)

VAR2CSA-Mediated Host Defense Evasion of Plasmodium falciparum Infected Erythrocytes in Placental Malaria
por: Tomlinson, Alice, et al.
Publicado: (2021)

Plasmodium falciparum infection coinciding with the malaria vaccine candidate BK-SE36 administration interferes with the immune responses in Burkinabe children
por: Tiono, Alfred B., et al.
Publicado: (2023)

African-specific polymorphisms in Plasmodium falciparum serine repeat antigen 5 in Uganda and Burkina Faso clinical samples do not interfere with antibody response to BK-SE36 vaccination
por: Arisue, Nobuko, et al.
Publicado: (2022)

VAR2CSA binding phenotype has ancient origin and arose before Plasmodium falciparum crossed to humans: implications in placental malaria vaccine design
por: Gangnard, Stéphane, et al.
Publicado: (2019)

Disruption of Var2csa Gene Impairs Placental Malaria Associated Adhesion Phenotype
por: Viebig, Nicola K., et al.
Publicado: (2007)

Accelerated phase Ia/b evaluation of the malaria vaccine candidate PfAMA1 DiCo demonstrates broadening of humoral immune responses
por: Remarque, Edmond J., et al.
Publicado: (2021)

Aotus nancymaae model predicts human immune response to the placental malaria vaccine candidate VAR2CSA
por: Doritchamou, Justin, et al.
Publicado: (2023)

Safety and immunogenicity of BK-SE36 in a blinded, randomized, controlled, age de-escalating phase Ib clinical trial in Burkinabe children
por: Bougouma, Edith Christiane, et al.
Publicado: (2022)

Pipeline analysis of a vaccine candidate portfolio for diseases of poverty using the Portfolio-To-Impact modelling tool
por: Gunn, Alexander, et al.
Publicado: (2020)

Safety and immunogenicity of BK-SE36/CpG malaria vaccine in healthy Burkinabe adults and children: a phase 1b randomised, controlled, double-blinded, age de-escalation trial
por: Ouédraogo, Alphonse, et al.
Publicado: (2023)

Workshop on Harmonic Oscillators
por: Collective
Publicado: (1992)

The Influence of Sub-Unit Composition and Expression System on the Functional Antibody Response in the Development of a VAR2CSA Based Plasmodium falciparum Placental Malaria Vaccine
por: Nielsen, Morten A., et al.
Publicado: (2015)

Placental malaria and low birth weight in pregnant women living in a rural area of Burkina Faso following the use of three preventive treatment regimens
por: Tiono, Alfred B, et al.
Publicado: (2009)

Specific Immunoassays for Placental Alkaline Phosphatase As a Tumor Marker
por: Stinghen, Sérvio T., et al.
Publicado: (2006)

Expression and Purification of scFv(2H7)-P18F3, a Bi-Modular Fusion Protein (BMFP) Targeting Human CD20
por: Brousse, Carine, et al.
Publicado: (2023)

Impact of exposure to malaria and nutritional status on responses to the experimental malaria vaccine ChAd63 MVA ME-TRAP in 5-17 month-old children in Burkina Faso
por: Morter, Richard, et al.
Publicado: (2022)

Workshop Report on Global Harmonization of Enterovirus Vaccines
por: Weng, Tzu-Yu, et al.
Publicado: (2020)

New-Generation Quantitative Immunoassays for SARS-CoV-2 Antibody Detection: Need for Harmonization
por: Villalta, Danilo, et al.
Publicado: (2022)

Particle counting immunoassay (PACIA) V- its application to the determination of human placental lactogen
por: Leek, A. E., et al.
Publicado: (1980)

Contribution of the Rapid LAMP-Based Diagnostic Test (RLDT) to the Evaluation of Enterotoxigenic Escherichia coli (ETEC) and Shigella in Childhood Diarrhea in the Peri-Urban Area of Ouagadougou, Burkina Faso
por: Héma, Alimatou, et al.
Publicado: (2023)

Fulani show decreased susceptibility to Plasmodium falciparum infection versus Mossi: data from a community-wide screening and treatment of asymptomatic carriers in Burkina Faso
por: Tiono, Alfred B, et al.
Publicado: (2013)

Protective Antibodies against Placental Malaria and Poor Outcomes during Pregnancy, Benin
por: Ndam, Nicaise Tuikue, et al.
Publicado: (2015)

Clinical Trials Cannot Substitute for Health System Strengthening Initiatives or Specifically Designed Health Policy and Systems Research
por: Asante, Kwaku Poku, et al.
Publicado: (2016)

Editorial: Understanding the materno-fetal interface during microbial infections, Volume II
por: Sarr, Demba, et al.
Publicado: (2022)

Submicroscopic placental infection by non-falciparum Plasmodium spp.
por: Doritchamou, Justin Y. A., et al.
Publicado: (2018)

Beninese children with cerebral malaria do not develop humoral immunity against the IT4-VAR19-DC8 PfEMP1 variant linked to EPCR and brain endothelial binding
por: Nunes-Silva, Sofia, et al.
Publicado: (2015)

Erratum to: Beninese children with cerebral malaria do not develop humoral immunity against the IT4-VAR19-DC8 PfEMP1 variant linked to EPCR and brain endothelial binding
por: Nunes-Silva, Sofia, et al.
Publicado: (2016)

Llama immunization with full-length VAR2CSA generates cross-reactive and inhibitory single-domain antibodies against the DBL1X domain
por: Nunes-Silva, Sofia, et al.
Publicado: (2014)

ABO blood group and the risk of placental malaria in sub-Saharan Africa
por: Adegnika, Ayola A, et al.
Publicado: (2011)

Can complement fix placental malaria?
por: Doritchamou, Justin Y. A., et al.
Publicado: (2021)

First field efficacy trial of the ChAd63 MVA ME-TRAP vectored malaria vaccine candidate in 5-17 months old infants and children
por: Tiono, Alfred B., et al.
Publicado: (2018)

Comparison between Amnisure Placental Alpha Microglobulin-1 Rapid Immunoassay and Standard Diagnostic Methods for Detection of Rupture of Membranes
por: Ng, Beng Kwang, et al.
Publicado: (2013)

On harmonic morphisms projecting harmonic functions to harmonic functions
por: Mustafa, M T
Publicado: (2002)

Structure of the DBL3X-DBL4ε region of the VAR2CSA placental malaria vaccine candidate: insight into DBL domain interactions
por: Gangnard, Stéphane, et al.
Publicado: (2015)

Determination of reference intervals for common chemistry and immunoassay tests for Kenyan adults based on an internationally harmonized protocol and up-to-date statistical methods
por: Omuse, Geoffrey, et al.
Publicado: (2020)

Antibody-Dependent Cellular Inhibition Is Associated With Reduced Risk Against Febrile Malaria in a Longitudinal Cohort Study Involving Ghanaian Children
por: Tiendrebeogo, Regis W., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_uaavpkvn0ds7mum5vt2ubh1dug